Mace KF - Search Results

1

Pharmacokinetics and pharmacodynamics of exenatide extended-release after single and multiple dosing.

Fineman M, Flanagan S, Taylor K, Aisporna M, Shen LZ, Mace KF, Walsh B, Diamant M, Cirincione B, Kothare P, Li WI, MacConell L. Fineman M, et al. Among authors: mace kf. Clin Pharmacokinet. 2011 Jan;50(1):65-74. doi: 10.2165/11585880-000000000-00000. Clin Pharmacokinet. 2011. PMID: 21142268

2

Clinical relevance of anti-exenatide antibodies: safety, efficacy and cross-reactivity with long-term treatment.

Fineman MS, Mace KF, Diamant M, Darsow T, Cirincione BB, Booker Porter TK, Kinninger LA, Trautmann ME. Fineman MS, et al. Among authors: mace kf. Diabetes Obes Metab. 2012 Jun;14(6):546-54. doi: 10.1111/j.1463-1326.2012.01561.x. Epub 2012 Feb 10. Diabetes Obes Metab. 2012. PMID: 22236356

3

Effect of renal impairment on the pharmacokinetics of exenatide.

Linnebjerg H, Kothare PA, Park S, Mace K, Reddy S, Mitchell M, Lins R. Linnebjerg H, et al. Br J Clin Pharmacol. 2007 Sep;64(3):317-27. doi: 10.1111/j.1365-2125.2007.02890.x. Epub 2007 Apr 10. Br J Clin Pharmacol. 2007. PMID: 17425627 Free PMC article. Clinical Trial.

4

Effect of exenatide on gastric emptying and relationship to postprandial glycemia in type 2 diabetes.

Linnebjerg H, Park S, Kothare PA, Trautmann ME, Mace K, Fineman M, Wilding I, Nauck M, Horowitz M. Linnebjerg H, et al. Regul Pept. 2008 Nov 29;151(1-3):123-9. doi: 10.1016/j.regpep.2008.07.003. Epub 2008 Jul 16. Regul Pept. 2008. PMID: 18675854 Clinical Trial.

5

Pharmacokinetics, pharmacodynamics, tolerability, and safety of exenatide in Japanese patients with type 2 diabetes mellitus.

Kothare PA, Linnebjerg H, Isaka Y, Uenaka K, Yamamura A, Yeo KP, de la Peña A, Teng CH, Mace K, Fineman M, Shigeta H, Sakata Y, Irie S. Kothare PA, et al. J Clin Pharmacol. 2008 Dec;48(12):1389-99. doi: 10.1177/0091270008323750. J Clin Pharmacol. 2008. PMID: 19047364 Clinical Trial.

6

Exenatide effects on statin pharmacokinetics and lipid response.

Kothare PA, Linnebjerg H, Skrivanek Z, Reddy S, Mace K, Pena A, Han J, Fineman M, Mitchell M. Kothare PA, et al. Int J Clin Pharmacol Ther. 2007 Feb;45(2):114-20. doi: 10.5414/cpp45114. Int J Clin Pharmacol Ther. 2007. PMID: 17323791 Clinical Trial.

7

The effect of exenatide on lisinopril pharmacodynamics and pharmacokinetics in patients with hypertension.

Linnebjerg H, Kothare P, Park S, Mace K, Mitchell M. Linnebjerg H, et al. Int J Clin Pharmacol Ther. 2009 Nov;47(11):651-8. doi: 10.5414/cpp47651. Int J Clin Pharmacol Ther. 2009. PMID: 19840529 Clinical Trial.

8

Effect of exenatide on the pharmacokinetics and pharmacodynamics of warfarin in healthy Asian men.

Soon D, Kothare PA, Linnebjerg H, Park S, Yuen E, Mace KF, Wise SD. Soon D, et al. Among authors: mace kf. J Clin Pharmacol. 2006 Oct;46(10):1179-87. doi: 10.1177/0091270006291622. J Clin Pharmacol. 2006. PMID: 16988207 Clinical Trial.

9

Safety, tolerability, pharmacokinetics, and pharmacodynamics of exenatide once weekly in Japanese patients with type 2 diabetes.

Iwamoto K, Nasu R, Yamamura A, Kothare PA, Mace K, Wolka AM, Linnebjerg H. Iwamoto K, et al. Endocr J. 2009;56(8):951-62. doi: 10.1507/endocrj.k09e-147. Epub 2009 Aug 25. Endocr J. 2009. PMID: 19706990 Free article. Clinical Trial.

10

Effect of exenatide on the pharmacokinetics of a combination oral contraceptive in healthy women: an open-label, randomised, crossover trial.

Kothare PA, Seger ME, Northrup J, Mace K, Mitchell MI, Linnebjerg H. Kothare PA, et al. BMC Clin Pharmacol. 2012 Mar 19;12:8. doi: 10.1186/1472-6904-12-8. BMC Clin Pharmacol. 2012. PMID: 22429273 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

27 results

Search Page